Keywords: ایمنی مواد مخدر; Drug safety; Drug control; Abuse liability; Biologics; Small molecule; Large molecule;
مقالات ISI ایمنی مواد مخدر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمنی مواد مخدر; Dialysis; end-stage renal disease (ESRD); hemodialysis; atrial fibrillation (AF); cardiac arrhythmia; warfarin; oral anticoagulation; drug safety; ischemic stroke; hemorrhagic stroke; bleeding; prevention; mortality;
Keywords: ایمنی مواد مخدر; Statins; Cognition; Memory; Adverse drug effects; Iatrogenesis; Drug safety;
Keywords: ایمنی مواد مخدر; Drug safety; Auditory function; Ageusia; Anosmia; Ototoxicity; Drug-induced sensory loss; Risk assessment; Method; Treatment adherence; Quality of life
Keywords: ایمنی مواد مخدر; Anticoagulants; Heparin; Drug safety; Cardiology;
Keywords: ایمنی مواد مخدر; Anti-TNF therapy; biologics registers; drug safety; rheumatoid arthritis; treatment outcome
Keywords: ایمنی مواد مخدر; Databases; Drug safety; High-potency; Kidney injury; Low-potency; Nested case-control study; Statins;
Keywords: ایمنی مواد مخدر; FDA; Drug safety; Risk evaluation and mitigation strategies; Drug regulation
Keywords: ایمنی مواد مخدر; antihyperglycemic agents; drug safety; hypoglycemia; inpatient diabetes management; insulin; medication errorsagents antihyperglycémiques; innocuité des médicaments; hypoglycémie; prise en charge du diabète en milieu hospitalier; insuline; erreurs de médi
Keywords: ایمنی مواد مخدر; Lithium; chronic kidney disease; nephrogenic diabetes insipidus; acute kidney disease; geriatric; drug safety;
Keywords: ایمنی مواد مخدر; Positive predictive value; Validation study; Non-steroidal anti-inflammatory agents; Drug safety; Signal detection; Upper gastrointestinal bleeding;
Keywords: ایمنی مواد مخدر; Drug safety; Risk management actions; Turkey;
Keywords: ایمنی مواد مخدر; Anemia; iron deficiency; iron treatment; drug safety
Adverse effects associated with collagenase clostridium histolyticum in Dupuytren disease: A prospective study
Keywords: ایمنی مواد مخدر; Collagenase clostridium histolitycum; Dupuytren disease; Drug safety; Complication; Effectiveness;
Dabigatran Reversal in a Patient With End-Stage Liver Disease and Acute Kidney Injury
Keywords: ایمنی مواد مخدر; Dabigatran; end-stage liver disease (ESLD); acute kidney injury (AKI); thrombin inhibitor; oral anticoagulant; renal clearance; hemorrhage; bleeding; dose adjustment; drug safety; decreased kidney function; idarucizumab;
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop
Keywords: ایمنی مواد مخدر; drug safety; oncology; patient-reported outcomes; PRO-CTCAE; tolerability;
Fluoroquinolone-Related Neuropsychiatric Events in Hospitalized Veterans
Keywords: ایمنی مواد مخدر; Fluoroquinolones; Adverse Drug Events; Antibiotics; Drug Safety; Infectious Diseases; Medication Safety;
Vaginal antimycotics and the risk for spontaneous abortions
Keywords: ایمنی مواد مخدر; antimycotics; clotrimazole; drug safety; miconazole; miscarriage; pregnancy; spontaneous abortions; teratogens;
Explaining resistance to system usage in the PharmaCloud: A view of the dual-factor model
Keywords: ایمنی مواد مخدر; PharmaCloud; Drug safety; User resistance; System use; Status quo bias;
Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology
Keywords: ایمنی مواد مخدر; Pharmacovigilance; FDA; MedDRA; Labeling; Drug Safety;
MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia
Keywords: ایمنی مواد مخدر; Tardive dyskinesia; Metoclopramide; Drug safety; Drug-drug interactions; Drug repurposing; Combination therapy;
Who seeks Teratology Information Service's advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy
Keywords: ایمنی مواد مخدر; Observational cohort study; Drug safety; Drug risks; Pregnancy; Socioeconomic status; Educational attainment;
Developmental Toxicity and Potential Teratogenicity of Compound Danshen Tablet, Angong Niuhuang Pill, and Lidan Paishi Tablet in Zebrafish Embryos
Keywords: ایمنی مواد مخدر; Chinese patent medicines; developmental toxicity; drug safety; potential teratogenicity; zebrafish embryos;
Pharmacovigilance system in Saudi Arabia
Keywords: ایمنی مواد مخدر; ADRs; Drug safety; Healthcare system; Pharmacovigilance; Risk management plan;
Postmarketing Surveillance Studies-An Industry Perspective on Changing Global Requirements and Implications
Keywords: ایمنی مواد مخدر; drug safety; postmarketing; risk management; surveillance;
Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4
Keywords: ایمنی مواد مخدر; aquaretic adverse events; autosomal dominant polycystic kidney disease; discontinuation; drug safety; tolerability; tolvaptan;
Drug Disposition Issues in CKD: Implications for Drug Discovery and Regulatory Approval
Keywords: ایمنی مواد مخدر; Drug disposition; CKD; Pharmacokinetics; Adverse events; Drug safety;
Challenges in evaluating cancer as a clinical outcome in postapproval studies of drug safety
Keywords: ایمنی مواد مخدر; Cancer epidemiology; Pharmacoepidemiology; Drug safety;
Impact du pharmacien clinicien à l'hôpital pour prévenir les posologies supra-thérapeutiques du paracétamol
Keywords: ایمنی مواد مخدر; Pharmacien clinicien; Paracétamol; Intervention pharmaceutique; Posologie supra-thérapeutique; Bon usage du médicament; Clinical pharmacist; Acetaminophen; Pharmaceutical interventions; Supra-therapeutic dosing of acetaminophen; Drug safety; Audit; Gui
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System
Keywords: ایمنی مواد مخدر; Dipeptidyl peptidase-4 inhibitors; Sitagliptin; Saxagliptin; Heart failure; Drug safety; Disproportionality; Spontaneous reporting system; FAERS
MicroRNA as biomarkers of mitochondrial toxicity
Keywords: ایمنی مواد مخدر; MicroRNA; Mitochondria; Toxicity; Drug safety;
Is sunitinib a Narrow Therapeutic Index Drug? - A systematic review and in vitro toxicology-analysis of Sunitinib vs. Imatinib in cells from different tissues
Keywords: ایمنی مواد مخدر; Apoptosis; Drug safety; Imatinib; Narrow Therapeutic Index Drug (NTID); Receptor tyrosine kinase (RTK); Sunitinib; Toxicity; Tyrosine kinase inhibitor (TKI); Cell viability; ALL; acute lymphoblastic leukemia; AUC; area under the curve; b.i.d.; twice daily
How to determine cardiac ion channels targeted by drugs using the isolated rabbit ventricular wedge model
Keywords: ایمنی مواد مخدر; Rabbit ventricular wedge assay; Drug safety; Tp-e/QT ratio; IKr blocker; QT-BCL slope; Positive staircase response of contractility; Use-dependency; Calcium channel blocker; Potassium channel activator;
Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD
Keywords: ایمنی مواد مخدر; Cholesterol; statin; CKD; cardiovascular disease; atherosclerotic cardiovascular disease; ASCVD; coronary heart disease; mortality; low density lipoprotein cholesterol; high density lipoprotein cholesterol; guidelines; lipids; treatment recommendations; d
Mortality Risk of Darbepoetin Alfa Versus Epoetin Alfa in Patients With CKD: Systematic Review and Meta-analysis
Keywords: ایمنی مواد مخدر; Erythropoiesis-stimulating agents; epoetin alfa (EPO); darbepoetin alfa (DPO); recombinant human erythropoietin (rHuEPO); mortality; drug safety; carbohydrate side chain; hemoglobin variability; anemia; chronic kidney disease (CKD); end-stage renal diseas
Impact de la mise en place d'un réseau régional de pharmacovigilance sur la notification d'effets indésirables : bilan à 3 ans
Keywords: ایمنی مواد مخدر; réseau de pharmacovigilance; audio-visioconférence; notification spontanée; information sur la sécurité des médicaments; pharmacovigilance; audio-videoconference; adverse drug reaction; spontaneous reporting; drug safety; AMM; autorisation de mise s
Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - A systematic review and meta-analysis
Keywords: ایمنی مواد مخدر; Cholesterol; Cardiovascular risk reduction; Drug safety; Complementary and alternative medicine;
Cadec: A corpus of adverse drug event annotations
Keywords: ایمنی مواد مخدر; Adverse drug reaction; Medical forum; SNOMED CT; MedDRA; Annotated corpus; Drug safety; Social media; Information extraction; Consumer reviews;
Language does not come “in boxes”: Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese
Keywords: ایمنی مواد مخدر; Adverse drug reactions; Spontaneous reporting; MedDRA; Pharmacovigilance; Drug safety; Portugal
Application of a discovery to targeted LC–MS proteomics approach to identify deregulated proteins associated with idiosyncratic liver toxicity in a rat model of LPS/diclofenac co-administration
Keywords: ایمنی مواد مخدر; Dcl, diclofenac; FIB, fibrinogen; KNT1, T-kininogen 1; LPS, lipopolysaccharide; MRM, multiple reaction monitoring; NSAID, nonsteroidal anti-inflammatory drugHepatotoxicity; Drug safety; Diclofenac; Proteomics
Pioglitazone use and the risk of bladder cancer
Keywords: ایمنی مواد مخدر; Bladder cancer; Diabetes; Drug safety; Pioglitazone
CAMTEA, un dispositif original de prescription encadrée hors-AMM de baclofène dans le Nord-Pas-de-Calais : quels rôles pour le pharmacien ?
Keywords: ایمنی مواد مخدر; Hors-AMM; Pharmacien; Sécurité médicamenteuse; Baclofène; Alcoolodépendance; Off-label; Pharmacist; Drug safety; Baclofen; Alcohol use disorder;
Dosing Errors in Prescribed Antibiotics for Older Persons With CKD: A Retrospective Time Series Analysis
Keywords: ایمنی مواد مخدر; Orally prescribed antibiotics; antibiotic dosing errors; renal disease; chronic kidney disease (CKD); estimated glomerular filtration rate (eGFR) reporting; nitrofurantoin; adverse drug event; quality of care; medical error; drug dosing adjustment; drug s
Research ArticleRivaroxaban postmarketing risk of liver injury
Keywords: ایمنی مواد مخدر; Rivaroxaban; Drug-induced liver injury; Hepatotoxicity; Adverse drug reactions; Postmarketing; Pharmacovigilance; Anticoagulants; Factor Xa inhibitors; Drug safety;
Plan estratégico integral de seguridad en el uso de medicamentos en un departamento sanitario
Keywords: ایمنی مواد مخدر; Plan de salud; Uso de medicamentos; Seguridad del medicamento; Health plan implementation; Drug use; Drug safety;
Kidney Function and Population-Based Outcomes of Initiating Oral Atenolol Versus Metoprolol Tartrate in Older Adults
Keywords: ایمنی مواد مخدر; Atenolol; metoprolol tartrate; chronic kidney disease (CKD); elderly; beta-blocker; bradycardia; hypotension; older adults; adverse events; drug safety; renal function;
Traitement anticholinergique de l'hyperactivité vésicale de la personne âgée et ses impacts sur la cognition. Revue de la littérature
Keywords: ایمنی مواد مخدر; Vessie hyperactive; Anticholinergiques; Système nerveux central; Altération cognitive; Effets secondaires; Overactive bladder; Anticholinergic drugs; Central nervous system; Cognitive impairment; Drug safety;
Renal Teratogens
Keywords: ایمنی مواد مخدر; Kidney development; Teratogens; Pregnancy; Drug safety;
Trastuzumab therapy in Australia: Which patients with HER2+ metastatic breast cancer are assessed for cardiac function?
Keywords: ایمنی مواد مخدر; Breast cancer; Trastuzumab; Cardiotoxicity; Drug safety; Data linkage;
Adverse drug reaction and concepts of drug safety in Ayurveda: An overview
Keywords: ایمنی مواد مخدر; Pharmacovigilance; ADR; Ayurveda; Drug safety; Abheshaja;